On July 11, 2012, Merus Labs International Inc. acquired Emselex®/Enablex®. Stewart Muglich and Victor Dudas of our Corporate Finance & Securities Group handled the debt facility between Merus and PDL BioPharma Inc., a company that supports the healthcare industry with creative financing solutions, assisted by Amaan Gangji and Kevin MacDonald. The transaction involved counsel from Toronto, New York, Switzerland, the Netherlands and Luxembourg.
Related Content
Veronica Franco on strata hearings
The March 31st edition of the Victoria Times Colonist quotes Veronica Franco extensively in the article “Be clear on purpose and format of a hearing”. ... Continued
Glen Boswall and Satinder Sidhu spoke at CSC event
Earlier today, Glen Boswall and Satinder Sidhu presented at a Construction Specifications Canada luncheon. On the subject of Design Professionals’ Liability, Glen and Satinder spoke ... Continued
CSA publishes mutual fund research and OSC releases whistleblower program
Bernard Pinsky is featured in the Advisor discussing the CSA’s mutual fund research and the OSC’s whistleblower program. Bernard explains that the CSA research makes ... Continued